DCGO (DocGo Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by DCGO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2025-12-16 | Stephen Sugrue | Chief Compliance Officer | MIXED | — | — |
| 2025-12-16 | Ely D Tendler | General Counsel and Secretary | MIXED | — | — |
| 2025-12-16 | Lee Bienstock | Chief Executive Officer | MIXED | — | — |
| 2025-12-16 | Etalvina Leite | Director | A | — | — |
| 2025-12-16 | JAMES M TRAVERS | Director | A | — | — |
| 2025-12-16 | NORMAN ROSENBERG | CFO and Treasurer | MIXED | — | — |
| 2025-12-16 | Michael J Burdiek | Director | A | — | — |
| 2025-12-16 | Ira Smedra | Director | A | — | — |
| 2025-09-11 | Stephen K. M.D. Klasko | Director | A | — | — |
| 2025-07-02 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2025-07-02 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2025-07-02 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2025-05-23 | Michael J Burdiek | Director | Buy | — | — |
| 2025-05-15 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2025-05-15 | Michael J Burdiek | Director | Buy | — | — |
| 2025-05-14 | Stephen K. M.D. Klasko | Director | Buy | — | — |
| 2025-05-14 | Lee Bienstock | Chief Executive Officer | Buy | — | — |
| 2025-05-14 | NORMAN ROSENBERG | CFO and Treasurer | Buy | — | — |
| 2025-05-14 | Stephen Sugrue | Chief Compliance Officer | Buy | — | — |
| 2025-04-02 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2025-04-02 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2025-04-02 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2025-03-11 | Stephen Sugrue | Chief Compliance Officer | MIXED | — | — |
| 2025-03-11 | NORMAN ROSENBERG | CFO and Treasurer | MIXED | — | — |
| 2025-03-11 | Lee Bienstock | Chief Executive Officer | MIXED | — | — |
| 2025-01-06 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2025-01-06 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2025-01-06 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2024-12-17 | Etalvina Leite | Director | MIXED | — | — |
| 2024-12-16 | Ely D Tendler | General Counsel and Secretary | MIXED | — | — |
| 2024-12-16 | Stephen Sugrue | Chief Compliance Officer | MIXED | — | — |
| 2024-12-16 | Michael J Burdiek | Director | A | — | — |
| 2024-12-16 | JAMES M TRAVERS | Director | A | — | — |
| 2024-12-16 | Lee Bienstock | Chief Executive Officer | MIXED | — | — |
| 2024-12-16 | Ira Smedra | Director | A | — | — |
| 2024-12-16 | NORMAN ROSENBERG | CFO and Treasurer | MIXED | — | — |
| 2024-10-04 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2024-10-04 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2024-10-04 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2024-07-09 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2024-07-09 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2024-07-09 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2024-06-24 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2024-06-18 | NORMAN ROSENBERG | CFO and Treasurer | F | — | — |
| 2024-06-18 | Stephen Sugrue | Chief Compliance Officer | F | — | — |
| 2024-06-18 | Lee Bienstock | Chief Executive Officer | F | — | — |
| 2024-05-14 | Michael J Burdiek | Director | Buy | — | — |
| 2024-05-13 | Lee Bienstock | Chief Executive Officer | Buy | — | — |
| 2024-05-13 | Ely D Tendler | General Counsel and Secretary | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 7,712,500 | — |
| — | Chief Executive Officer | 2,801,826 | — |
| — | CFO and Treasurer | 1,223,571 | — |
| — | See Remarks | 1,193,413 | — |
| — | Director | 791,560 | — |
| — | Chief Compliance Officer | 636,602 | — |
| — | Director | 632,027 | — |
| — | Chief Executive Officer | 404,275 | — |
| — | General Counsel and Secretary | 275,645 | — |
| — | Director | 240,999 | — |
| — | Director | 201,411 | — |
| — | Director | 115,000 | — |
| — | Director | 69,534 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DCGO quote page; the site-wide leaderboard is on the insider transactions hub.